Download Laboratory Diagnosis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Taura syndrome wikipedia , lookup

Hepatitis C wikipedia , lookup

Orthohantavirus wikipedia , lookup

Influenza A virus wikipedia , lookup

Canine distemper wikipedia , lookup

Marburg virus disease wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Canine parvovirus wikipedia , lookup

Henipavirus wikipedia , lookup

Hepatitis B wikipedia , lookup

Transcript
Islamic University
Gaza
CH34:LABORATORY DIAGNOSIS
PREPARD BY:
Basel Auda
PRESENTED TO:
Dr.Abdelraouf El Manamma
23-11-2008
Introduction






There are five approaches to the diagnosis of
viral infection:
(1) identification of the virus in cell culture
(2) microscopic identification directly in the
specimen
(3) serologic procedures to detect a rise in
antibody titer or the presence of IgM antibody
(4) detection of viral antigens in blood or body
fluids
(5) detection of viral nucleic acids in blood or
the patient's cells
Identification in Cell Culture
The growth of viruses requires cell cultures, because viruses replicate
only in living cells. Because many viruses are inactivated at room
temperature, it is important to inoculate the specimen into the cell
culture as soon as possible; brief transport or storage at 4°C is
acceptable
Virus growth in cell culture frequently produces a characteristic
cytopathic effect (CPE) that can provide a presumptive
identification.
CPE is a change in the appearance of the virus-infected cells. This
change can be in such features as size, shape, and the fusion of
cells to form multinucleated giant cells (syncytia).
CPE is usually a manifestation of virus-infected cells that are dying or
dead. The time taken for the CPE to appear and the type of cell in
which the virus produces the CPE are important clues in the
presumptive identification.
Cont.
If the virus does not produce a CPE, its presence can be detected by several
other techniques:
Hemadsorption, i.e., attachment of erythrocytes to the surface of virusinfected cells. This technique is limited to viruses with a hemagglutinin
protein on their envelope, such as mumps, parainfluenza, and influenza
viruses.
Interference with the formation of a CPE by a second virus. For example,
rubella virus, which does not cause a CPE, can be detected by interference
with the formation of a CPE by certain enteroviruses such as echovirus or
coxsackievirus.
A decrease in acid production by infected, dying cells. This can be
detected visually by a color change in the phenol red (a pH indicator) in the
culture medium. The indicator remains red (alkaline) in the presence of
virus-infected cells but turns yellow in the presence of metabolizing normal
cells as a result of the acid produced. This
definitive identification


A definitive identification of the virus grown
in cell culture is made by using known
antibody in one of several tests. Complement
fixation, hemagglutination inhibition, and
neutralization of the CPE are the most frequently
used tests.
Other procedures such as fluorescent antibody,
radioimmunoassay, enzyme-linked
immunosorbent assay (ELISA), and
immunoelectron microscopy are also used in
special instances.
Complement Fixation

If the antigen (the unknown virus in the
culture fluid) and the known antibody are
homologous, complement will be fixed to
the antigen–antibody complex. This makes
it unavailable to lyse the "indicator"
system, which is composed of sensitized
red blood cells.
Hemagglutination Inhibition
If the virus and antibody are homologous,
the virus is blocked from attaching to the
erythrocytes and no hemagglutination
occurs.
Only viruses that agglutinate red blood cells
can be identified by this method.
Neutralization
If the virus and antibody are homologous, the antibody
bound to the surface of the virus blocks its entry into the
cell.
This neutralizes viral infectivity, because it prevents viral
replication and subsequent CPE formation or animal
infection
Fluorescent-Antibody Assay
If the virus-infected cells and the fluoresceintagged antibody are homologous, the
typical apple-green color of fluorescein is
seen in the cells by ultraviolet (UV)
microscopy.
Radioimmunoassay
If the virus and the antibody are
homologous, there is less antibody
remaining to bind to the known
radiolabeled virus.
Enzyme-Linked
Immunosorbent Assay
In the ELISA test to identify a virus, known antibody
is bound to a surface. If the virus is present in the
patient's specimen, it will bind to the antibody.
A sample of the antibody linked to an enzyme is
added, which will attach to the bound virus.
The substrate of the enzyme is added and the amount
of the bound enzyme is determined
Immunoelectron Microscopy
If the antibody is homologous to the virus,
aggregates of virus–antibody complexes
are seen in the electron microscope
Microscopic Identification
Viruses can be detected and identified by direct microscopic
examination of clinical specimens such as biopsy material or skin
lesions. Three different procedures can be used.
Light microscopy can reveal characteristic inclusion bodies or
multinucleated giant cells. The Tzanck smear, which shows
herpesvirus-induced multinucleated giant cells in vesicular skin
lesions, is a good example.
(2) UV microscopy is used for fluorescent-antibody staining of the virus
in infected cells.
(3) Electron microscopy detects virus particles, which can be
characterized by their size and morphology.
Serologic Procedures
A rise in the titer of antibody to the virus can be
used to diagnose current infection.
Seroconversion is the term used to describe
the finding of antibody to a virus (or any
microbe) in a patient's serum who previously
had no antibody.
Stated another way, the patient's serum has
converted from antibody-negative to antibodypositive.
Cont.
A serum sample is obtained as soon as a viral etiology is
suspected (acute-phase), and a second sample is
obtained 10–14 days later (convalescent-phase).
If the antibody titer in the convalescent-phase serum
sample is at least fourfold higher than the titer in the
acute-phase serum sample, the patient is considered to
be infected
If, however, the titer in the convalescent-phase serum
sample is less than two folds this is not a significant rise
and should not be interpreted as a sign of recent
infection.
Cont.
It is important to realize that an antibody titer on a single
sample does not distinguish between a previous infection
and a current one. The antibody titer can be determined
by many of the immunologic tests mentioned above.
These serologic diagnoses are usually made
retrospectively, because the disease has frequently run
its course by the time the results are obtaied.
In certain viral diseases, the presence of IgM antibody is
used to diagnose current infection. For example, the
presence of IgM antibody to core antigen indicates
infection by hepatitis B virus.
Other nonspecific serologic tests are available. For
example, the heterophil antibody test (Monospot) can be
used to diagnose infectious mononucleosis
Detection of Viral Antigens
Viral antigens can be detected in the patient's
blood or body fluids by various tests but most
often by an ELISA.
Tests for the p24 antigen of human
immunodeficiency virus (HIV) and the surface
antigen of hepatitis B virus are common
examples of this approach
Detection of Viral Nucleic
Acids
Viral nucleic acids, i.e., either the viral genome or viral
mRNA, can be detected in the patient's blood or tissues
with complementary DNA or RNA (cDNA or cRNA) as a
probe.
If only small amounts of viral nucleic acids are present in
the patient, the PCR can be used to amplify the viral
nucleic acids.
Assays for the RNA of HIV in the patient's blood (viral load)
are commonly used to monitor the course of the disease
and to evaluate the
Thank you